Esperion Recalls
2 recalls on record · September 13, 2023 to April 24, 2024 · Drugs
Recalls by year
23
24
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
April 24, 2024DrugsFDA
Esperion recalls NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: Esperion Ther
Hazard: Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint.
September 13, 2023DrugsFDA
Esperion recalls Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeutics, Inc,
Hazard: Failed dissolution specifications: below specification results at stability 12-month